Invictus MD is a cannabis company founded in Vancouver, Canada.
We represent a platform of licensed producers, under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), dedicated to providing high-quality, regulated pharma-grade cannabis for medical and recreational use. Our growers are supported by over 250 acres of buildable property with full access to our team of industry-leading horticulturists, biochemists, and project managers.
We are committed to raising the professional status quo of this frontier industry. Through clean and organic cultivation practices, deep domain knowledge, and an experienced team to drive it all, Invictus MD is fully-equipped to lead the legal cannabis space, from Canada to the rest of the world.
With projections over $50 billion by 2025, legal cannabis is the fastest-growing industry to come in decades. Consumer demand isn’t slowing down anytime soon.
Marijuana as medicine
Patients and physicians are now seeing the health benefits of cannabis. It is now considered to be a natural, healthier, and safer remedy for a variety of ailments.
Experts in growth
Our team consists of award-winning horticulturalists, entrepreneurs, and management leaders who are experienced in growing companies from the ground up.
Dedicated to cultivating the highest in quality
Providing the safest product for our patients is a commitment we take seriously. That’s why every aspect of our growing methodology—the soil, fertiliser, and even how we test for quality—is done in a natural, organic way.
Every step is regulated and standardized in a controlled environment. We combine the latest in monitoring technology with proven agricultural techniques to ensure that every strain coming out of our licensed production facilities meets our high quality standards.
Powering the future of legal marijuana
Invictus MD is strategically positioned to grow alongside the legal cannabis industry as it matures into a mainstream market. Our facilities are fully expandable, which enables our licensed producers to fully meet the exploding demand of both medical and soon to be recreational use.
We plan to continuously innovate our cultivation process and carry out long-term expansion plans to strengthen our production capacity. Our focus is on gaining first-mover advantage as soon as proper legislative regulations liberate the market.
GET OUR INVESTOR DECK
- Breakdown of facilities
- Capitalization structure
- Future Harvest performance
- Company road map from going public
- Combined Cannabis Production Profile
- Management & Board of Directors
Vancouver, BC, January 16, 2018 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS1) is pleased to reaffirm its increased target capacity to 76,000 kg based on expanding facilities in 2019 to approximately 520,000 square feet outlined on January 16, 2018. Dan Kriznic, Invictus MD Chairman and CEO […]
Invictus MD Receives $9.5 million from Warrant and Option Exercises and Increases Target Capacity in 2019 to 76,000 kg15Jan
Vancouver, BC, January 15, 2018 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS1) is pleased to announce that since the release of its financial results for the third quarter ended October 31, 2017, which were filed on SEDAR on December 22, 2017, the Company has received $9,484,547 […]
Invictus MD to Increase Investment in AB Laboratories; AB Laboratories Receives Sales License; AB Laboratories, AB Ventures and Acreage Pharms Target over 26,000 kg Capacity in 20188Jan
Vancouver, BC, January 8, 2018 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS1) is pleased to announce that the Company has entered into a Letter of Intent (“LOI”) to make a further strategic investment in the licensed production facility under the Access to Cannabis for Medical Purposes […]